Cover Image
Market Research Report

Preimplantation Genetic Testing (PGT) (PGS/PGD) Market Size, Share & Trends Analysis Report By PGD/PGS, By Type (Embryo Testing, Aneuploidy Screening), By Application, And Segment Forecasts, 2019 - 2024

Published by Grand View Research, Inc. Product code 398904
Published Content info 170 Pages
Delivery time: 2-3 business days
Price
Back to Top
Preimplantation Genetic Testing (PGT) (PGS/PGD) Market Size, Share & Trends Analysis Report By PGD/PGS, By Type (Embryo Testing, Aneuploidy Screening), By Application, And Segment Forecasts, 2019 - 2024
Published: April 8, 2019 Content info: 170 Pages
Description

The global preimplantation genetic testing market is expected to reach USD 107.3 million by 2024, at a CAGR of 6.2% over the forecast period, according to a new report by Grand View Research, Inc. It is primarily driven by a rising awareness among couples to undergo diagnostic and screening tests to minimize genetic diseases and aneuploidy in fetus. The ability of preimplantation genetic testing to detect genetic disorders and rare diseases, such as fibrodysplasia ossificans progressive, is anticipated to propel the growth.

High adoption of In Vitro Fertilization (IVF) technique consequently upsurges the utilization of Preimplantation Genetic Diagnosis (PGD). These techniques are advantageous in a way that they allow the development of a healthy fetus and prevent the risk of selective pregnancy termination. Hence, PGT acts as an addendum to assisted reproductive technology.

A substantial number of patients with infertility and impaired fecundity are recommended to embrace IVF therapy in combination with PGT procedures, which in turn is expected to stimulate the growth. In addition, public and private authorities are promoting reproductive health by undertaking initiatives is also anticipated to drive the Preimplantation Genetic Testing (PGT) (PGS/PGD) market.

Further key findings from the report suggest:

Availability of a significant number of services related to early diagnosis of specific gene mutation in embryo marked the dominant position of PGD in 2018

Preimplantation Genetic Screening (PGS) seems to be reasonable intervention to enhance efficiency of selecting chromosomally normal embryo during IVF cycles. It is increasingly being applied for embryo screening due to ever-expanding IVF, which is projected to create lucrative growth opportunities in near future

Advancements in detection of chromosomal anomalies by executing non-invasive prenatal testing results in a maximum share of this segment in 2018

Expanding utilization rate of FISH probe sets and benefits associated with the detection of a single-gene disorder is expected to fuel the growth of X-linked diseases segment

Implementation of PGT in embryo HLA typing for stem cell therapy is expected to impose segment growth. This is further attributed to the advantages pertaining to PGS testing for identification of HLA compatible embryos during stem cell therapy

Europe accounts for largest revenue share in 2018 owing to increased usage of PGD and PGS for the delivery of genetically healthy offspring during IVF procedures

Asia Pacific market is observed to reveal the fastest CAGR due to the rise in medical tourism and the continuous development of IVF and PGD clinics in Asian countries

Key players that have commercialized PGT services include Natera, Inc.; CooperSurgical, Inc.; F. Hoffmann-La Roche AG; Illumina, Inc.; IGENOMIX; and others

Key participants are actively involved in expansion of the distribution network for their products as well as R&D activities for the development of novel PGT services. In October 2018, Illumina Inc. signed an agreement with Vitrolife AB under which Vitrolife act as a distributor supplier of Illumina's PGT products in EMEA and America.

Table of Contents
Product Code: GVR-1-68038-276-1

Table of Contents

Chapter 1 Research Methodology & Scope

  • 1.1 Market Segmentation & Scope
  • 1.2 Market Definition
  • 1.3 Information Procurement
    • 1.3.1 Purchased database
    • 1.3.2 GVR's internal database
    • 1.3.3 Secondary sources & third party perspectives
    • 1.3.4 Primary research
  • 1.4 Information Analysis
    • 1.4.1 Data analysis models
  • 1.5 Market Formulation & Data Visualization
  • 1.6 Data Validation & Publishing

Chapter 2 Executive Summary

  • 2.1 Preimplantation Genetic Testing (PGT) (PGS/PGD) Market Outlook, 2014 - 2024
  • 2.2 Preimplantation Genetic Testing (PGT) (PGS/PGD) Market : Segment Outlook, 2014 - 2024
  • 2.3 Preimplantation Genetic Testing (PGT) (PGS/PGD) Market : Competitive Insights

Chapter 3 Preimplantation Genetic Testing (PGT) (PGS/PGD) Market Variables, Trends& Scope

  • 3.1 Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2 Penetration & Growth Prospect Mapping, 2018
  • 3.3 Product Pipeline Analysis, by Stage
  • 3.4 Cost Structure Analysis
  • 3.5 User Perspective Analysis
    • 3.5.1. Consumer behavior analysis
    • 3.5.2. Market influencer analysis
  • 3.6 Procedure Cost Analysis/Breakdown
  • 3.7 End-use analysis
  • 3.8 Regulatory Framework
    • 3.8.1. Reimbursement framework
    • 3.8.2. Standards & compliances
  • 3.9 Preimplantation Genetic Testing (PGT) (PGS/PGD) Market - Market Dynamics
    • 3.9.1 Market driver analysis
      • 3.9.1.1 Rising incidences of genetic diseases
      • 3.9.1.2 Demand for healthy and successful embryo implantation
      • 3.9.1.3 Increase in rate of infertility
    • 3.9.2 Market Restraint Analysis
      • 3.9.2.1 Ethical and legal constraints
    • 3.9.3 Market challenges analysis
      • 3.9.3.1 Challenges related to invasive embryo biopsy during PGD
  • 3.10 Preimplantation Genetic Testing (PGT) (PGS/PGD) Market Analysis Tools
    • 3.10.1 Industry Analysis - Porter's
      • 3.10.1.1 Supplier power : Moderate bargaining power of suppliers owing to low switiching cost
      • 3.10.1.2 Buyer power: Increase in cost containment results in moderate bargaing power of buyer
      • 3.10.1.3 Substitution threat: Low threat of substitution due to stringent approval procedure
      • 3.10.1.4 Threat from new entrant: Threat of new entrant is low as high capital is required for PGT set up
      • 3.10.1.5 Competitive rivalry: There is high competitive rivalry owing to high demand of IVF technology
    • 3.10.2 PESTEL analysis
      • 3.10.2.1 Political landscape
      • 3.10.2.2 Environmental landscape
      • 3.10.2.3 Social landscape
      • 3.10.2.4 Technology landscape
      • 3.10.2.5 Legal landscape
    • 3.10.3 Major deals & strategic alliances analysis
      • 3.10.3.1 Joint ventures
      • 3.10.3.2 Mergers & acquisitions
      • 3.10.3.3 Licensing & partnership
      • 3.10.3.4 Technology collaborations
      • 3.10.3.5 Strategic divestments
    • 3.10.4 Market entry strategies
    • 3.10.5 Case studies
  • 3.11 Global preimplantation genetic testing (PGT)(PGS/PGD) company market share, 2018
  • 3.12 U.S. preimplantation genetic testing (PGT)(PGS/PGD)company market share, 2018
  • 3.13 Platform comparison
    • 3.13.1 Share break-up analysis in terms of commercial test kits (Veriseq, Reproseq) v/s in-house developed PGD/PGS testing
      • 3.13.1.1 Veriseq
      • 3.13.1.2 Reproseq
      • 3.13.1.3 Other Kits

Chapter 4 Preimplantation Genetic Testing (PGT) (PGS/PGD) Market: Competitive Analysis

  • 4.1 Recent Developments & Impact Analysis, by Key Market Participants
  • 4.2 Company/Competition Categorization
  • 4.3 Vendor Landscape
    • 4.3.1 Distribution network
    • 4.3.2 Key customers
    • 4.3.3 Key company market share analysis, 2018
  • 4.4 Public Companies
    • 4.4.1 Company market position analysis
    • 4.4.2 Company market share by region
    • 4.4.3 Competitive dashboard analysis
    • 4.4.4 Market differentiators
    • 4.4.5 Synergy analysis: Major deals & strategic alliances
  • 4.5 Private Companies
    • 4.5.1 List of key emerging companies
    • 4.5.2 Funding outlook
    • 4.5.3 Regional network map
    • 4.5.4 Company market position analysis

Chapter 5 Preimplantation Genetic Testing (PGT) (PGS/PGD) Market: PGD/PGS Estimates & Trend Analysis

  • 5.1 Definitions & Scope
  • 5.2 PGD/PGS Market Share Analysis, 2018 & 2024
  • 5.3 Preimplantation Genetic Testing (PGT) (PGS/PGD) Market Share by PGD/PGS, 2014 to 2024
  • 5.4 Global Preimplantation Genetic Testing (PGT) (PGS/PGD) Market by PGD/PGS, 2014 to 2024
  • 5.5 Market Size & Forecasts and Trend Analyses, 2014 to 2024 for the following,
    • 5.5.1 PGD
      • 5.5.1.1 Global PGD market, 2014 - 2024 (USD Million)
      • 5.5.1.2 Pricing Analysis of PGD tests
      • 5.5.1.3 PGD lab revenue, 2014 - 2024, by lab size, (USD Million)
      • 5.5.1.3.1 High
      • 5.5.1.3.1.1 High capacity PGD labs market, 2014 - 2024, by region
      • 5.5.1.3.2 Medium
      • 5.5.1.3.2.1 Medium capacity PGD labs market, 2014 - 2024, by region
      • 5.5.1.3.3 Low
      • 5.5.1.3.3.1 Low capacity PGD labs market, 2014 - 2024, by region
      • 5.5.1.4 Number of labs offering PGD in different regions
      • 5.5.1.5 Number of IVF cycles for PGD in different regions
      • 5.5.1.6 PGD Technology Analysis
      • 5.5.1.6.1 aCGH
      • 5.5.1.6.1.1 aCGH capacity PGD labs market, 2014 - 2024, by region
      • 5.5.1.6.2 NGS
      • 5.5.1.6.2.1 NGS capacity PGD labs market, 2014 - 2024, by region
      • 5.5.1.6.3 Other technologies
      • 5.5.1.3.6.1 Other technologies capacity PGD labs market, 2014 - 2024, by region
    • 5.5.2 PGS
      • 5.5.2.1 Global PGS market, 2014 - 2024 (USD Million)
      • 5.5.2.2 Pricing Analysis of PGS tests
      • 5.5.2.3 PGS lab revenue, 2014 - 2024, by lab size, (USD Million)
      • 5.5.2.3.1 High
      • 5.5.2.3.1.1 High capacity PGS labs market, 2014 - 2024, by region
      • 5.5.2.3.2 Medium
      • 5.5.2.3.2.1 Medium capacity PGS labs market, 2014 - 2024, by region
      • 5.5.2.3.3 Low
      • 5.5.2.3.3.1 Low capacity PGS labs market, 2014 - 2024, by region
      • 5.5.2.4 Number of labs offering PGS in different regions
      • 5.5.2.5 Number of IVF cycles for PGS in different regions
      • 5.5.2.6 PGD Technology Analysis
      • 5.5.2.6.1 aCGH
      • 5.5.2.6.1.1 PGS - aCGH market, 2014 - 2024, by region
      • 5.5.2.6.2 NGS
      • 5.5.2.6.2.1 PGS - NGS market, 2014 - 2024, by region
      • 5.5.2.6.3 Other technologies
      • 5.5.2.3.6.1 PGS - Others technologies market, 2014 - 2024, by region
  • 5.6 Preimplantation Genetic Testing (PGT) (PGS/PGD) Market, by Application, 2014 to 2024

Chapter 6 Preimplantation Genetic Testing (PGT) (PGS/PGD) Market: Types Estimates & Trend Analysis

  • 6.1. Definitions & Scope
  • 6.2. Type Market Share Analysis, 2018 & 2024
  • 6.3 Preimplantation Genetic Testing (PGT) (PGS/PGD) Market: End-use Movement Analysis, 2018 & 2024
  • 6.4. Global Preimplantation Genetic Testing (PGT) (PGS/PGD) Market, by Type, 2014 to 2024
  • 6.5 Market Size & Forecasts and Trend Analyses, 2014 to 2024 for the following,
    • 6.5.1 X-linked diseases
      • 6.5.1.1 Global X-linked diseases market, 2014 - 2024 (USD Million)
    • 6.5.2 Embryo testing
      • 6.5.2.1 Global embryo testing market, 2014 - 2024 (USD Million)
      • 6.5.2.2 Fresh embryo (own eggs)
      • 6.5.2.2.1 Global fresh embryo (own eggs) testing market, 2014 - 2024 (USD Million)
      • 6.5.2.3 Frozen embryo (own eggs)
      • 6.5.2.3.1 Global frozen embryo (own eggs) testing market, 2014 - 2024 (USD Million)
      • 6.5.2.4 Fresh embryo (donor eggs)
      • 6.5.2.4.1 Global fresh embryo (donor eggs) testing market, 2014 - 2024 (USD Million)
      • 6.5.2.5 Frozen embryo (donor eggs)
      • 6.5.2.5.1 Global frozen embryo (donor eggs) testing market, 2014 - 2024 (USD Million)
    • 6.5.3 Aneuploidy screening
      • 6.5.3.1 Global aneuploidy screening market, 2014 - 2024 (USD Million)
    • 6.5.4 HLA typing
      • 6.5.4.1 Global HLA typing market, 2014 - 2024 (USD Million)
    • 6.5.5 Other PGT (PGD/PGS) test types
      • 6.5.5.1 Global other PGT (PGD/PGS) test types market, 2014 - 2024 (USD Million)

Chapter 7 Preimplantation Genetic Testing (PGT) (PGS/PGD) Market: Application Estimates & Trend Analysis

  • 7.1 Definitions & Scope
  • 7.2 Application Market Share Analysis, 2018 & 2024
  • 7.3 Preimplantation Genetic Testing (PGT) (PGS/PGD) Market: End-use Movement Analysis, 2018 & 2024
  • 7.4. Global Preimplantation Genetic Testing (PGT) (PGS/PGD) Market, by Application, 2014 to 2024
  • 7.5 Market Size & Forecasts and Trend Analyses, 2014 to 2024 for the following,
    • 7.5.1 Identifying embryo for stem cell therapy
      • 7.5.1.1 Global identifying embryo for stem cell therapy market, 2014 - 2024 (USD Million)
    • 7.5.2 IVF prognosis
      • 7.5.2.1 Global IVF prognosis market, 2014 - 2024 (USD Million)
    • 7.5.3 Late onset genetic disorders
      • 7.5.3.1 Global late onset genetic disorders market, 2014 - 2024 (USD Million)
    • 7.5.4 Inherited genetic disease
      • 7.5.4.1 Global inherited genetic disease market, 2014 - 2024 (USD Million)
    • 7.5.5 Others
      • 7.5.5.1 Global other application market, 2014 - 2024 (USD Million)

Chapter 8 Preimplantation Genetic Testing (PGT) (PGS/PGD) Market: Regional Estimates & Trend Analysis, by Product, Type & Application

  • 8.1 Preimplantation Genetic Testing (PGT) (PGS/PGD) Market Share by Region, 2018 & 2024
  • 8.2 Regional Market Share and Leading Players, 2018
    • 8.2.1 North America
    • 8.2.2 Europe
    • 8.2.3 Asia Pacific
    • 8.2.4 Latin America
    • 8.2.5 Middle East & Africa
  • 8.3 North America
    • 8.3.1 Preimplantation genetic testing (PGT) (PGS/PGD) market, 2014 - 2024 (USD Million)
    • 8.3.2 U.S.
      • 8.3.2.1 Preimplantation genetic testing (PGT) (PGS/PGD) market, by PGD/PGS, 2014 - 2024 (USD Million)
      • 8.3.2.2 Preimplantation genetic testing (PGT) (PGS/PGD) market, by type, 2014 - 2024 (USD Million)
      • 8.3.2.3 Preimplantation genetic testing (PGT) (PGS/PGD) market, by application, 2014 - 2024 (USD Million)
    • 8.3.3 Canada
      • 8.3.3.1 Preimplantation genetic testing (PGT) (PGS/PGD) market, by PGD/PGS, 2014 - 2024 (USD Million)
      • 8.3.3.2 Preimplantation genetic testing (PGT) (PGS/PGD) market, by type, 2014 - 2024 (USD Million)
      • 8.3.3.3 Preimplantation genetic testing (PGT) (PGS/PGD) market, by application, 2014 - 2024 (USD Million)
  • 8.4 Europe
    • 8.4.1 Europe preimplantation genetic testing (PGT) (PGS/PGD) market, 2014 - 2024 (USD Million)
    • 8.4.2 Germany
      • 8.4.2.1 Preimplantation genetic testing (PGT) (PGS/PGD) market, by PGD/PGS, 2014 - 2024 (USD Million)
      • 8.4.2.2 Preimplantation genetic testing (PGT) (PGS/PGD) market, by type, 2014 - 2024 (USD Million)
      • 8.4.2.3 Preimplantation genetic testing (PGT) (PGS/PGD) market, by application, 2014 - 2024 (USD Million)
    • 8.4.3 U.K.
      • 8.4.3.1 Preimplantation genetic testing (PGT) (PGS/PGD) market, by PGD/PGS, 2014 - 2024 (USD Million)
      • 8.4.3.2 Preimplantation genetic testing (PGT) (PGS/PGD) market, by type, 2014 - 2024 (USD Million)
      • 8.4.3.3 Preimplantation genetic testing (PGT) (PGS/PGD) market, by application, 2014 - 2024 (USD Million)
    • 8.4.4 Spain
      • 8.4.4.1 Preimplantation genetic testing (PGT) (PGS/PGD) market, by PGD/PGS, 2014 - 2024 (USD Million)
      • 8.4.4.2 Preimplantation genetic testing (PGT) (PGS/PGD) market, by type, 2014 - 2024 (USD Million)
      • 8.4.4.3 Preimplantation genetic testing (PGT) (PGS/PGD) market, by application, 2014 - 2024 (USD Million)
    • 8.4.5 Belgium
      • 8.4.5.1 Preimplantation genetic testing (PGT) (PGS/PGD) market, by PGD/PGS, 2014 - 2024 (USD Million)
      • 8.4.5.2 Preimplantation genetic testing (PGT) (PGS/PGD) market, by type, 2014 - 2024 (USD Million)
      • 8.4.5.3 Preimplantation genetic testing (PGT) (PGS/PGD) market, by application, 2014 - 2024 (USD Million)
    • 8.4.6 Czech Republic
      • 8.4.6.1 Preimplantation genetic testing (PGT) (PGS/PGD) market, by PGD/PGS, 2014 - 2024 (USD Million)
      • 8.4.6.2 Preimplantation genetic testing (PGT) (PGS/PGD) market, by type, 2014 - 2024 (USD Million)
      • 8.4.6.3 Preimplantation genetic testing (PGT) (PGS/PGD) market, by application, 2014 - 2024 (USD Million)
    • 8.4.7 Poland
      • 8.4.7.1 Preimplantation genetic testing (PGT) (PGS/PGD) market, by PGD/PGS, 2014 - 2024 (USD Million)
      • 8.4.7.2 Preimplantation genetic testing (PGT) (PGS/PGD) market, by type, 2014 - 2024 (USD Million)
      • 8.4.7.3 Preimplantation genetic testing (PGT) (PGS/PGD) market, by application, 2014 - 2024 (USD Million)
    • 8.4.8 Sweden
      • 8.4.8.1 Preimplantation genetic testing (PGT) (PGS/PGD) market, by PGD/PGS, 2014 - 2024 (USD Million)
      • 8.4.8.2 Preimplantation genetic testing (PGT) (PGS/PGD) market, by type, 2014 - 2024 (USD Million)
      • 8.4.8.3 Preimplantation genetic testing (PGT) (PGS/PGD) market, by application, 2014 - 2024 (USD Million)
    • 8.4.9 Finland
      • 8.4.9.1 Preimplantation genetic testing (PGT) (PGS/PGD) market, by PGD/PGS, 2014 - 2024 (USD Million)
      • 8.4.9.2 Preimplantation genetic testing (PGT) (PGS/PGD) market, by type, 2014 - 2024 (USD Million)
      • 8.4.9.3 Preimplantation genetic testing (PGT) (PGS/PGD) market, by application, 2014 - 2024 (USD Million)
    • 8.4.10 Norway
      • 8.4.10.1 Preimplantation genetic testing (PGT) (PGS/PGD) market, by PGD/PGS, 2014 - 2024 (USD Million)
      • 8.4.10.2 Preimplantation genetic testing (PGT) (PGS/PGD) market, by type, 2014 - 2024 (USD Million)
      • 8.4.10.3 Preimplantation genetic testing (PGT) (PGS/PGD) market, by application, 2014 - 2024 (USD Million)
    • 8.4.11 Netherlands
      • 8.4.11.1 Preimplantation genetic testing (PGT) (PGS/PGD) market, by PGD/PGS, 2014 - 2024 (USD Million)
      • 8.4.11.2 Preimplantation genetic testing (PGT) (PGS/PGD) market, by type, 2014 - 2024 (USD Million)
      • 8.4.11.3 Preimplantation genetic testing (PGT) (PGS/PGD) market, by application, 2014 - 2024 (USD Million)
    • 8.4.12 Italy
      • 8.4.12.1 Preimplantation genetic testing (PGT) (PGS/PGD) market, by PGD/PGS, 2014 - 2024 (USD Million)
      • 8.4.12.2 Preimplantation genetic testing (PGT) (PGS/PGD) market, by type, 2014 - 2024 (USD Million)
      • 8.4.12.3 Preimplantation genetic testing (PGT) (PGS/PGD) market, by application, 2014 - 2024 (USD Million)
  • 8.5 Asia Pacific
    • 8.5.1 Asia Pacific preimplantation genetic testing (PGT) (PGS/PGD) market, 2014 - 2024 (USD Million)
    • 8.5.2 Japan
      • 8.5.2.1 Preimplantation genetic testing (PGT) (PGS/PGD) market, by PGD/PGS, 2014 - 2024 (USD Million)
      • 8.5.2.2 Preimplantation genetic testing (PGT) (PGS/PGD) market, by type, 2014 - 2024 (USD Million)
      • 8.5.2.3 Preimplantation genetic testing (PGT) (PGS/PGD) market, by application, 2014 - 2024 (USD Million)
    • 8.5.3 China
      • 8.5.3.1 Preimplantation genetic testing (PGT) (PGS/PGD) market, by PGD/PGS, 2014 - 2024 (USD Million)
      • 8.5.3.2 Preimplantation genetic testing (PGT) (PGS/PGD) market, by type, 2014 - 2024 (USD Million)
      • 8.5.3.3 Preimplantation genetic testing (PGT) (PGS/PGD) market, by application, 2014 - 2024 (USD Million)
    • 8.5.4 India
      • 8.5.4.1 Preimplantation genetic testing (PGT) (PGS/PGD) market, by PGD/PGS, 2014 - 2024 (USD Million)
      • 8.5.4.2 Preimplantation genetic testing (PGT) (PGS/PGD) market, by type, 2014 - 2024 (USD Million)
      • 8.5.4.3 Preimplantation genetic testing (PGT) (PGS/PGD) market, by application, 2014 - 2024 (USD Million)
    • 8.5.5 Singapore
      • 8.5.5.1 Preimplantation genetic testing (PGT) (PGS/PGD) market, by PGD/PGS, 2014 - 2024 (USD Million)
      • 8.5.5.2 Preimplantation genetic testing (PGT) (PGS/PGD) market, by type, 2014 - 2024 (USD Million)
      • 8.5.5.3 Preimplantation genetic testing (PGT) (PGS/PGD) market, by application, 2014 - 2024 (USD Million)
    • 8.5.6 Malaysia
      • 8.5.6.1 Preimplantation genetic testing (PGT) (PGS/PGD) market, by PGD/PGS, 2014 - 2024 (USD Million)
      • 8.5.6.2 Preimplantation genetic testing (PGT) (PGS/PGD) market, by type, 2014 - 2024 (USD Million)
      • 8.5.6.3 Preimplantation genetic testing (PGT) (PGS/PGD) market, by application, 2014 - 2024 (USD Million)
  • 8.6 Latin America
    • 8.6.1 Latin America preimplantation genetic testing (PGT) (PGS/PGD) market, 2014 - 2024 (USD Million)
    • 8.6.2 Brazil
      • 8.6.2.1 Preimplantation genetic testing (PGT) (PGS/PGD) market, by PGD/PGS, 2014 - 2024 (USD Million)
      • 8.6.2.2 Preimplantation genetic testing (PGT) (PGS/PGD) market, by type, 2014 - 2024 (USD Million)
      • 8.6.2.3 Preimplantation genetic testing (PGT) (PGS/PGD) market, by application, 2014 - 2024 (USD Million)
    • 8.6.3 Mexico
      • 8.6.3.1 Preimplantation genetic testing (PGT) (PGS/PGD) market, by PGD/PGS, 2014 - 2024 (USD Million)
      • 8.6.3.2 Preimplantation genetic testing (PGT) (PGS/PGD) market, by type, 2014 - 2024 (USD Million)
      • 8.6.3.3 Preimplantation genetic testing (PGT) (PGS/PGD) market, by application, 2014 - 2024 (USD Million)
    • 8.6.4 Argentina
      • 8.6.4.1 Preimplantation genetic testing (PGT) (PGS/PGD) market, by PGD/PGS, 2014 - 2024 (USD Million)
      • 8.6.4.2 Preimplantation genetic testing (PGT) (PGS/PGD) market, by type, 2014 - 2024 (USD Million)
      • 8.6.4.3 Preimplantation genetic testing (PGT) (PGS/PGD) market, by application, 2014 - 2024 (USD Million)
    • 8.6.5 Chile
      • 8.6.5.1 Preimplantation genetic testing (PGT) (PGS/PGD) market, by PGD/PGS, 2014 - 2024 (USD Million)
      • 8.6.5.2 Preimplantation genetic testing (PGT) (PGS/PGD) market, by type, 2014 - 2024 (USD Million)
      • 8.6.5.3 Preimplantation genetic testing (PGT) (PGS/PGD) market, by application, 2014 - 2024 (USD Million)
  • 8.7 Middle East & Africa
    • 8.7.1 Middle East & Africa preimplantation genetic testing (PGT) (PGS/PGD) market, 2014 - 2024 (USD Million)
    • 8.7.2 South Africa
      • 8.7.2.1 Preimplantation genetic testing (PGT) (PGS/PGD) market, by PGD/PGS, 2014 - 2024 (USD Million)
      • 8.7.2.2 Preimplantation genetic testing (PGT) (PGS/PGD) market, by type, 2014 - 2024 (USD Million)
      • 8.7.2.3 Preimplantation genetic testing (PGT) (PGS/PGD) market, by application, 2014 - 2024 (USD Million)

Chapter 9 Pricing Analysis & Regulatory Framework Country-wise Customization

  • 9.1 U.S.
    • 9.1.1 Pricing analysis for PGD/PGS Tests
    • 9.1.2 Regulatory framework for PGD/PGS Tests
  • 9.2 Canada
    • 9.2.1 Pricing analysis for PGD/PGS Tests
    • 9.2.2 Regulatory framework for PGD/PGS Tests
  • 9.3 Germany
    • 9.3.1 Pricing analysis for PGD/PGS Tests
    • 9.3.2 Regulatory framework for PGD/PGS Tests
  • 9.4 U.K.
    • 9.4.1 Pricing analysis for PGD/PGS Tests
    • 9.4.2 Regulatory framework for PGD/PGS Tests
  • 9.5 Spain
    • 9.5.1 Pricing analysis for PGD/PGS Tests
    • 9.5.2 Regulatory framework for PGD/PGS Tests
  • 9.6 Belgium
    • 9.6.1 Pricing analysis for PGD/PGS Tests
    • 9.6.2 Regulatory framework for PGD/PGS services
  • 9.7 Czech Republic
    • 9.7.1 Pricing analysis for PGD/PGS Tests
    • 9.7.2 Regulatory framework for PGD/PGS Tests
  • 9.8 Poland
    • 9.8.1 Pricing analysis for PGD/PGS Tests
    • 9.8.2 Regulatory framework for PGD/PGS Tests
  • 9.9 Sweden
    • 9.9.1 Pricing analysis for PGD/PGS Tests
    • 9.9.2 Regulatory framework for PGD/PGS Tests
  • 9.10 Finland
    • 9.10.1 Pricing analysis for PGD/PGS Tests
    • 9.10.2 Regulatory framework for PGD/PGS Tests
  • 9.11 Norway
    • 9.11.1 Pricing analysis for PGD/PGS Tests
    • 9.11.2 Regulatory framework for PGD/PGS services
  • 9.12 Netherlands
    • 9.12.1 Pricing analysis for PGD/PGS Tests
    • 9.12.2 Regulatory framework for PGD/PGS Tests
  • 9.13 Italy
    • 9.13.1 Pricing analysis for PGD/PGS Tests
    • 9.13.2 Regulatory framework for PGD/PGS Tests
  • 9.14 Japan
    • 9.14.1 Pricing analysis for PGD/PGS Tests
    • 9.14.2 Regulatory framework for PGD/PGS Tests
  • 9.15 China
    • 9.15.1 Pricing analysis for PGD/PGS Tests
    • 9.15.2 Regulatory framework for PGD/PGS Tests
  • 9.16 India
    • 9.16.1 Pricing analysis for PGD/PGS Tests
    • 9.16.2 Regulatory framework for PGD/PGS Tests
  • 9.17 Singapore
    • 9.17.1 Pricing analysis for PGD/PGS Tests
    • 9.17.2 Regulatory framework for PGD/PGS Tests
  • 9.18 Malaysia
    • 9.18.1 Pricing analysis for PGD/PGS Tests
    • 9.18.2 Regulatory framework for PGD/PGS Tests
  • 9.19 Brazil
    • 9.19.1 Pricing analysis for PGD/PGS Tests
    • 9.19.2 Regulatory framework for PGD/PGS Tests
  • 9.20 Argentina
    • 9.20.1 Pricing analysis for PGD/PGS Tests
    • 9.20.2 Regulatory framework for PGD/PGS Tests
  • 9.21 Chile
    • 9.21.1 Pricing analysis for PGD/PGS Tests
    • 9.21.2 Regulatory framework for PGD/PGS Tests
  • 9.22 South Africa
    • 9.22.1 Pricing analysis for PGD/PGS Tests
    • 8.22.2 Regulatory framework for PGD/PGS Tests

Chapter 10 Competitive Landscape

  • 10.1 Strategy framework
  • 10.2 Market participation categorization
  • 10.3 Company Profiles
    • 10.3.1 F. Hoffmann-La Roche Ltd.
      • 10.3.1.1 Company overview
      • 10.3.1.1.1 Ariosa Diagnostics
      • 10.3.1.2 Financial Performance
      • 10.3.1.3 Product benchmarking
      • 10.3.1.4 Strategic initiatives
    • 10.3.2 Genea Limited
      • 10.3.2.1 Company overview
      • 10.3.2.2 Financial performance
      • 10.3.2.3 Product benchmarking
      • 10.3.2.4 Strategic initiatives
    • 10.3.3 Quest Diagnostics Incorporated
      • 10.3.3.1 Company overview
      • 10.3.3.2 Financial performance
      • 10.3.3.3 Product benchmarking
      • 10.3.3.4 Strategic initiatives
    • 10.3.4 Illumina, Inc.
      • 10.3.4.1 Company overview
      • 10.3.4.2 Financial performance
      • 10.3.4.3 Product benchmarking
      • 10.3.4.4 Strategic initiatives
    • 10.3.5 Natera, Inc.
      • 10.3.5.1 Company overview
      • 10.3.5.2 Financial performance
      • 10.3.5.3 Product benchmarking
      • 10.3.5.4 Strategic initiatives
    • 10.3.6 CooperSurgical, Inc.
      • 10.3.6.1 Company overview
      • 10.3.6.1.1 Genesis Genetics
      • 10.3.6.1.2 Reprogenetics
      • 10.3.6.2 Financial performance
      • 10.3.6.2.1 Financial performance (Genesis Genetics)
      • 10.3.6.2.2 Financial performance (Reprogenetics)
      • 10.3.6.3 Product benchmarking
      • 10.3.6.4 Strategic initiatives
    • 10.3.7 Laboratory Corporation of America Holdings
      • 10.3.7.1 Company overview
      • 10.3.7.1.1 Sequenom
      • 10.3.7.2 Financial performance
      • 10.3.7.2.1 Financial performance (Sequenom)
      • 10.3.7.3 Product benchmarking
      • 10.3.7.4 Strategic initiatives
    • 10.3.8 California Pacific Medical Center (CPMC)
      • 10.3.8.1 Company overview
      • 10.3.8.2 Financial performance
      • 10.3.8.3 Product benchmarking
      • 10.3.8.4 Strategic initiatives
    • 10.3.9 Thermo Fisher Scientific, Inc.
      • 10.3.9.1 Company overview
      • 10.3.9.2 Financial performance
      • 10.3.9.3 Product benchmarking
      • 10.3.9.4 Strategic initiatives
    • 10.3.10 IGENOMIX
      • 10.3.10.1 Company overview
      • 10.3.10.2 Financial performance
      • 10.3.10.3 Product benchmarking
      • 10.3.10.4 Strategic initiatives
    • 10.3.11 Reproductive Genetic Innovations, LLC
      • 10.3.11.1 Company overview
      • 10.3.11.2 Financial performance
      • 10.3.11.3 Product benchmarking
      • 10.3.11.4 Strategic initiatives
    • 10.3.12 Invitae Corporation
      • 10.3.12.1 Company overview
      • 10.3.12.1.1 CombiMatrix
      • 10.3.12.1.2 Good Start Genetics, Inc.
      • 10.3.12.2 Financial performance
      • 10.3.12.3 Product benchmarking
      • 10.3.12.4 Strategic initiatives
    • 10.3.13 Oxford Gene Technology
      • 10.3.13.1 Company overview
      • 10.3.13.2 Financial performance
      • 10.3.13.3 Product benchmarking
      • 10.3.13.4 Strategic initiatives
    • 10.3.14 Bioarray S.L.
      • 10.3.14.1 Company overview
      • 10.3.14.2 Financial performance
      • 10.3.14.3 Product benchmarking
      • 10.3.14.4 Strategic initiatives
    • 10.3.15 PerkinElmer Inc.
      • 10.3.15.1 Company overview
      • 10.3.15.1.1 RHS Ltd.
      • 10.3.15.2 Financial performance
      • 10.3.15.3 Product benchmarking
      • 10.3.15.4 Strategic initiatives
  • 10.4 List of Companies

List of Tables

  • TABLE 1 Global incidence rate of genetic disorders
  • TABLE 2 Global PGD/PGS NGS Revenue, by Kit Type, 2014 - 2018 (USD Million)
  • TABLE 3 Global PGD/PGS NGS Revenue, by Kit Type, 2019-2024 (USD Million)
  • TABLE 4 Regional PGD/PGS VeriSeq & ReproSeq Kits, by Region, 2014 - 2018 (USD Million)
  • TABLE 5 Regional PGD/PGS VeriSeq & ReproSeq Kits, by Region, 2019 - 2024 (USD Million)
  • TABLE 6 Regional PGD/PGS Other Kits, by Region, 2014 - 2018 (USD Million)
  • TABLE 7 Regional PGD/PGS Other Kits, by Region, 2019 - 2024 (USD Million)
  • TABLE 8 Costs for PGD
  • TABLE 9 High capacity PGD labs market estimates, 2014 - 2018, by region
  • TABLE 10 High capacity PGD labs market estimates, 2019 - 2024, by region
  • TABLE 11 Medium capacity PGD labs market estimates, 2014 - 2018, by region
  • TABLE 12 Medium capacity PGD labs market estimates, 2019 - 2024, by region
  • TABLE 13 Low capacity PGD labs market estimates, 2014 - 2018, by region
  • TABLE 14 Low capacity PGD labs market estimates, 2019 - 2024, by region
  • TABLE 15 Number of labs offering PGD in different regions
  • TABLE 16 Number of IVF cycles for PGD in different regions
  • TABLE 17 Comparison aCGH and NGS results for copy number variation analysis
  • TABLE 18 PGD - aCGH market, 2014 - 2024, by region
  • TABLE 19 PGD - NGS market, 2014 - 2024, by region
  • TABLE 20 PGD - Other technologies market, 2014 - 2024, by region
  • TABLE 21 Price break-up depending on the number of embryos
  • TABLE 22 High capacity PGS labs market, 2014 - 2018, by region
  • TABLE 23 High capacity PGS labs market, 2019 - 2024, by region
  • TABLE 24 Medium capacity PGS labs market, 2014 - 2018, by region
  • TABLE 25 Medium capacity PGS labs market, 2019 - 2024, by region
  • TABLE 26 Low capacity PGS labs market, 2014 - 2018, by region
  • TABLE 27 Low capacity PGS labs market, 2019 - 2024, by region
  • TABLE 28 Number of labs offering PGS in different regions
  • TABLE 29 Number of IVF cycles for PGS in different regions
  • TABLE 30 PGS - aCGH market, 2014 - 2024, by region
  • TABLE 31 PGS - NGS market, 2014 - 2024, by region
  • TABLE 32 Comparison of other technologies
  • TABLE 33 PGS - Others technologies market, 2014 - 2024, by region (USD Million)
  • TABLE 34 Risk of aneuploidy with rising maternal age
  • TABLE 35 North America PGT (PGD/PGS) market estimates, by types, 2014 - 2018 (USD Million)
  • TABLE 36 North America PGT (PGD/PGS) market forecasts, by types, 2019 - 2024 (USD Million)
  • TABLE 37 North America PGD/PGS embryo testing market, by type, 2014 - 2018 (USD Million)
  • TABLE 38 North America PGD/PGS embryo testing market, by type, 2019 - 2024 (USD Million)
  • TABLE 39 North America PGT (PGD/PGS) market estimates, by application, 2014 - 2018 (USD Million)
  • TABLE 40 North America PGT (PGD/PGS) market forecasts, by application, 2019 - 2024 (USD Million)
  • TABLE 41 U.S. PGT (PGD/PGS) market estimates, by types, 2014 - 2018 (USD Million)
  • TABLE 42 U.S. PGT (PGD/PGS) market forecasts, by types, 2019 - 2024 (USD Million)
  • TABLE 43 U.S. PGD/PGS embryo testing market, by type, 2014 - 2018 (USD Million)
  • TABLE 44 U.S. PGD/PGS embryo testing market, by type, 2019 - 2024 (USD Million)
  • TABLE 45 U.S. PGT (PGD/PGS) market estimates, by application, 2014 - 2018 (USD Million)
  • TABLE 46 U.S. PGT (PGD/PGS) market forecasts, by application, 2019 - 2024 (USD Million)
  • TABLE 47 Canada PGT (PGD/PGS) market estimates, by types, 2014 - 2018 (USD Million)
  • TABLE 48 Canada PGT (PGD/PGS) market forecasts, by types, 2019 - 2024 (USD Million)
  • TABLE 49 Canada PGD/PGS embryo testing market, by type, 2014 - 2018 (USD Million)
  • TABLE 50 Canada PGD/PGS embryo testing market, by type, 2019 - 2024 (USD Million)
  • TABLE 51 Canada PGT (PGD/PGS) market estimates, by application, 2014 - 2018 (USD Million)
  • TABLE 52 Canada PGT (PGD/PGS) market forecasts, by application, 2019 - 2024 (USD Million)
  • TABLE 53 Europe PGT (PGD/PGS) market estimates, by types, 2014 - 2018 (USD Million)
  • TABLE 54 Europe PGT (PGD/PGS) market forecasts, by types, 2019 - 2024 (USD Million)
  • TABLE 55 Europe PGD/PGS embryo testing market, by type, 2014 - 2018 (USD Million)
  • TABLE 56 Europe PGD/PGS embryo testing market, by type, 2019 - 2024 (USD Million)
  • TABLE 57 Europe PGT (PGD/PGS) market estimates, by application, 2014 - 2018 (USD Million)
  • TABLE 58 Europe PGT (PGD/PGS) market forecasts, by application, 2019 - 2024 (USD Million)
  • TABLE 59 Germany PGT (PGD/PGS) market estimates, by types, 2014 - 2018 (USD Million)
  • TABLE 60 Germany PGT (PGD/PGS) market forecasts, by types, 2019 - 2024 (USD Million)
  • TABLE 61 Germany PGD/PGS embryo testing market, by type, 2014 - 2018 (USD Million)
  • TABLE 62 Germany PGD/PGS embryo testing market, by type, 2019 - 2024 (USD Million)
  • TABLE 63 Germany PGT (PGD/PGS) market estimates, by application, 2014 - 2018 (USD Million)
  • TABLE 64 Germany PGT (PGD/PGS) market forecasts, by application, 2019 - 2024 (USD Million)
  • TABLE 65 U.K. PGT (PGD/PGS) market estimates, by types, 2014 - 2018 (USD Million)
  • TABLE 66 U.K. PGT (PGD/PGS) market forecasts, by types, 2019 - 2024 (USD Million)
  • TABLE 67 U.K. PGD/PGS embryo testing market, by type, 2014 - 2018 (USD Million)
  • TABLE 68 U.K. PGD/PGS embryo testing market, by type, 2019 - 2024 (USD Million)
  • TABLE 69 U.K. PGT (PGD/PGS) market estimates, by application, 2014 - 2018 (USD Million)
  • TABLE 70 U.K. PGT (PGD/PGS) market forecasts, by application, 2019 - 2024 (USD Million)
  • TABLE 71 Asia Pacific PGT (PGD/PGS) market estimates, by types, 2014 - 2018 (USD Million)
  • TABLE 72 Asia Pacific PGT (PGD/PGS) market forecasts, by types, 2019 - 2024 (USD Million)
  • TABLE 73 Asia Pacific PGD/PGS embryo testing market, by type, 2014 - 2018 (USD Million)
  • TABLE 74 Asia Pacific PGD/PGS embryo testing market, by type, 2019 - 2024 (USD Million)
  • TABLE 75 Asia Pacific PGT (PGD/PGS) market estimates, by application, 2014 - 2018 (USD Million)
  • TABLE 76 Asia Pacific PGT (PGD/PGS) market forecasts, by application, 2019 - 2024 (USD Million)
  • TABLE 77 Japan PGT (PGD/PGS) market estimates, by types, 2014 - 2018 (USD Million)
  • TABLE 78 Japan PGT (PGD/PGS) market forecasts, by types, 2019 - 2024 (USD Million)
  • TABLE 79 Japan PGD/PGS embryo testing market, by type, 2014 - 2018 (USD Million)
  • TABLE 80 Japan PGD/PGS embryo testing market, by type, 2019 - 2024 (USD Million)
  • TABLE 81 Japan PGT (PGD/PGS) market estimates, by application, 2014 - 2018 (USD Million)
  • TABLE 82 Japan PGT (PGD/PGS) market forecasts, by application, 2019 - 2024 (USD Million)
  • TABLE 83 China PGT (PGD/PGS) market estimates, by types, 2014 - 2018 (USD Million)
  • TABLE 84 China PGT (PGD/PGS) market forecasts, by types, 2019 - 2024 (USD Million)
  • TABLE 85 China PGD/PGS embryo testing market, by type, 2014 - 2018 (USD Million)
  • TABLE 86 China PGD/PGS embryo testing market, by type, 2019 - 2024 (USD Million)
  • TABLE 87 China PGT (PGD/PGS) market estimates, by application, 2014 - 2018 (USD Million)
  • TABLE 88 China PGT (PGD/PGS) market forecasts, by application, 2019 - 2024 (USD Million)
  • TABLE 89 Latin America PGT (PGD/PGS) market estimates, by types, 2014 - 2018 (USD Million)
  • TABLE 90 Latin America PGT (PGD/PGS) market forecasts, by types, 2019 - 2024 (USD Million)
  • TABLE 91 Latin America PGD/PGS embryo testing market, by type, 2014 - 2018 (USD Million)
  • TABLE 92 Latin America PGD/PGS embryo testing market, by type, 2019 - 2024 (USD Million)
  • TABLE 93 Latin America PGT (PGD/PGS) market estimates, by application, 2014 - 2018 (USD Million)
  • TABLE 94 Latin America PGT (PGD/PGS) market forecasts, by application, 2019 - 2024 (USD Million)
  • TABLE 95 Brazil PGT (PGD/PGS) market estimates, by types, 2014 - 2018 (USD Million)
  • TABLE 96 Brazil PGT (PGD/PGS) market forecasts, by types, 2019 - 2024 (USD Million)
  • TABLE 97 Brazil PGD/PGS embryo testing market, by type, 2014 - 2018 (USD Million)
  • TABLE 98 Brazil PGD/PGS embryo testing market, by type, 2019 - 2024 (USD Million)
  • TABLE 99 Brazil PGT (PGD/PGS) market estimates, by application, 2014 - 2018 (USD Million)
  • TABLE 100 Brazil PGT (PGD/PGS) market forecasts, by application, 2019 - 2024 (USD Million)
  • TABLE 101 Mexico PGT (PGD/PGS) market estimates, by types, 2014 - 2018 (USD Million)
  • TABLE 102 Mexico PGT (PGD/PGS) market forecasts, by types, 2019 - 2024 (USD Million)
  • TABLE 103 Mexico PGD/PGS embryo testing market, by type, 2014 - 2018 (USD Million)
  • TABLE 104 Mexico PGD/PGS embryo testing market, by type, 2019 - 2024 (USD Million)
  • TABLE 105 Mexico PGT (PGD/PGS) market estimates, by application, 2014 - 2018 (USD Million)
  • TABLE 106 Mexico PGT (PGD/PGS) market forecasts, by application, 2019 - 2024 (USD Million)
  • TABLE 107 Middle East & Africa PGT (PGD/PGS) market estimates, by types, 2014 - 2018 (USD Million)
  • TABLE 108 Middle East & Africa PGT (PGD/PGS) market forecasts, by types, 2019 - 2024 (USD Million)
  • TABLE 109 MEA PGD/PGS embryo testing market, by type, 2014 - 2018 (USD Million)
  • TABLE 110 MEA PGD/PGS embryo testing market, by type, 2019 - 2024 (USD Million)
  • TABLE 111 Middle East & Africa PGT (PGD/PGS) market estimates, by application, 2014 - 2018 (USD Million)
  • TABLE 112 Middle East & Africa PGT (PGD/PGS) market forecasts, by application, 2019 - 2024 (USD Million)
  • TABLE 113 South Africa PGT (PGD/PGS) market estimates, by types, 2014 - 2018 (USD Million)
  • TABLE 114 South Africa PGT (PGD/PGS) market forecasts, by types, 2019 - 2024 (USD Million)
  • TABLE 115 South Africa PGD/PGS embryo testing market, by type, 2014 - 2018 (USD Million)
  • TABLE 116 South Africa U.S. PGD/PGS embryo testing market, by type, 2019 - 2024 (USD Million)
  • TABLE 117 South Africa PGT (PGD/PGS) market estimates, by application, 2014 - 2018 (USD Million)
  • TABLE 118 South Africa PGT (PGD/PGS) market forecasts, by application, 2019 - 2024 (USD Million)
  • TABLE 119 Average preimplantation genetic testing costs in the U.S.
  • TABLE 120 Average preimplantation genetic testing costs in the Canada
  • TABLE 121 Average preimplantation genetic testing costs in the Canada
  • TABLE 122 Average preimplantation genetic testing costs in U.K.
  • TABLE 123 Preimplantation genetic testing costs in Spain
  • TABLE 124 Spain PGT (PGD/PGS) market estimates, by types, 2014 - 2018 (USD Million)
  • TABLE 125 Spain PGT (PGD/PGS) market forecasts, by types, 2019 - 2024 (USD Million)
  • TABLE 126 Spain PGD/PGS embryo testing market, by type, 2014 - 2018 (USD Million)
  • TABLE 127 Spain PGD/PGS embryo testing market, by type, 2019 - 2024 (USD Million)
  • TABLE 128 Spain PGT (PGD/PGS) market estimates, by application, 2014 - 2018 (USD Million)
  • TABLE 129 Spain PGT (PGD/PGS) market forecasts, by application, 2019 - 2024 (USD Million)
  • TABLE 130 Preimplantation genetic testing costs in Belgium
  • TABLE 131 Belgium PGT (PGD/PGS) market estimates, by types, 2014 - 2018 (USD Million)
  • TABLE 132 Belgium PGT (PGD/PGS) market forecasts, by types, 2019 - 2024 (USD Million)
  • TABLE 133 Belgium PGD/PGS embryo testing market, by type, 2014 - 2018 (USD Million)
  • TABLE 134 Belgium PGD/PGS embryo testing market, by type, 2019 - 2024 (USD Million)
  • TABLE 135 Belgium PGT (PGD/PGS) market estimates, by application, 2014 - 2018 (USD Million)
  • TABLE 136 Belgium PGT (PGD/PGS) market forecasts, by application, 2019 - 2024 (USD Million)
  • TABLE 137 Average preimplantation genetic testing costs in Czech Republic
  • TABLE 138 Czech Republic PGT (PGD/PGS) market estimates, by types, 2014 - 2018 (USD Million)
  • TABLE 139 Czech Republic PGT (PGD/PGS) market forecasts, by types, 2019 - 2024 (USD Million)
  • TABLE 140 Czech Republic PGD/PGS embryo testing market, by type, 2014 - 2018 (USD Million)
  • TABLE 141 Czech Republic PGD/PGS embryo testing market, by type, 2019 - 2024 (USD Million)
  • TABLE 142 Czech Republic PGT (PGD/PGS) market estimates, by application, 2014 - 2018 (USD Million)
  • TABLE 143 Czech Republic PGT (PGD/PGS) market forecasts, by application, 2019 - 2024 (USD Million)
  • TABLE 144 Average preimplantation genetic testing costs in Poland
  • TABLE 145 Poland PGT (PGD/PGS) market estimates, by types, 2014 - 2018 (USD Million)
  • TABLE 146 Poland PGT (PGD/PGS) market forecasts, by types, 2019 - 2024 (USD Million)
  • TABLE 147 Poland PGD/PGS embryo testing market, by type, 2014 - 2018 (USD Million)
  • TABLE 148 Poland PGD/PGS embryo testing market, by type, 2019 - 2024 (USD Million)
  • TABLE 149 Poland PGT (PGD/PGS) market estimates, by application, 2014 - 2018 (USD Million)
  • TABLE 150 Poland PGT (PGD/PGS) market forecasts, by application, 2019 - 2024 (USD Million)
  • TABLE 151 Sweden PGT (PGD/PGS) market estimates, by types, 2014 - 2018 (USD Million)
  • TABLE 152 Sweden PGT (PGD/PGS) market forecasts, by types, 2019 - 2024 (USD Million)
  • TABLE 153 Sweden PGD/PGS embryo testing market, by type, 2014 - 2018 (USD Million)
  • TABLE 154 Sweden PGD/PGS embryo testing market, by type, 2019 - 2024 (USD Million)
  • TABLE 155 Sweden PGT (PGD/PGS) market estimates, by application, 2014 - 2018 (USD Million)
  • TABLE 156 Sweden PGT (PGD/PGS) market forecasts, by application, 2019 - 2024 (USD Million)
  • TABLE 157 Average preimplantation genetic testing costs in Finland
  • TABLE 158 Finland PGT (PGD/PGS) market estimates, by types, 2014 - 2018 (USD Million)
  • TABLE 159 Finland PGT (PGD/PGS) market forecasts, by types, 2019 - 2024 (USD Million)
  • TABLE 160 Finland PGD/PGS embryo testing market, by type, 2014 - 2018 (USD Million)
  • TABLE 161 Finland PGD/PGS embryo testing market, by type, 2019 - 2024 (USD Million)
  • TABLE 162 Finland PGT (PGD/PGS) market estimates, by application, 2014 - 2018 (USD Million)
  • TABLE 163 Finland PGT (PGD/PGS) market forecasts, by application, 2019 - 2024 (USD Million)
  • TABLE 164 Preimplantation genetic testing costs in Norway
  • TABLE 165 Norway PGT (PGD/PGS) market estimates, by types, 2014 - 2018 (USD Million)
  • TABLE 166 Norway PGT (PGD/PGS) market forecasts, by types, 2019 - 2024 (USD Million)
  • TABLE 167 Norway PGD/PGS embryo testing market, by type, 2014 - 2018 (USD Million)
  • TABLE 168 Norway PGD/PGS embryo testing market, by type, 2019 - 2024 (USD Million)
  • TABLE 169 Norway PGT (PGD/PGS) market estimates, by application, 2014 - 2018 (USD Million)
  • TABLE 170 Norway PGT (PGD/PGS) market forecasts, by application, 2019 - 2024 (USD Million)
  • TABLE 171 Preimplantation genetic testing costs in Netherlands
  • TABLE 172 Netherlands PGT (PGD/PGS) market estimates, by types, 2014 - 2018 (USD Million)
  • TABLE 173 Netherlands PGT (PGD/PGS) market forecasts, by types, 2019 - 2024 (USD Million)
  • TABLE 174 Netherlands PGD/PGS embryo testing market, by type, 2014 - 2018 (USD Million)
  • TABLE 175 Netherlands PGD/PGS embryo testing market, by type, 2019 - 2024 (USD Million)
  • TABLE 176 Netherlands PGT (PGD/PGS) market estimates, by application, 2014 - 2018 (USD Million)
  • TABLE 177 Netherlands PGT (PGD/PGS) market forecasts, by application, 2019 - 2024 (USD Million)
  • TABLE 178 Preimplantation genetic testing costs in Italy
  • TABLE 179 Italy PGT (PGD/PGS) market estimates, by types, 2014 - 2018 (USD Million)
  • TABLE 180 Italy PGT (PGD/PGS) market forecasts, by types, 2019 - 2024 (USD Million)
  • TABLE 181 Italy PGD/PGS embryo testing market, by type, 2014 - 2018 (USD Million)
  • TABLE 182 Italy PGD/PGS embryo testing market, by type, 2019 - 2024 (USD Million)
  • TABLE 183 Italy PGT (PGD/PGS) market estimates, by application, 2014 - 2018 (USD Million)
  • TABLE 184 Italy PGT (PGD/PGS) market forecasts, by application, 2019 - 2024 (USD Million)
  • TABLE 185 Average preimplantation genetic testing costs in Japan
  • TABLE 186 Average preimplantation genetic testing costs in China
  • TABLE 187 Preimplantation genetic testing costs in India
  • TABLE 188 India PGT (PGD/PGS) market estimates, by types, 2014 - 2018 (USD Million)
  • TABLE 189 India PGT (PGD/PGS) market forecasts, by types, 2019 - 2024 (USD Million)
  • TABLE 190 India PGD/PGS embryo testing market, by type, 2014 - 2018 (USD Million)
  • TABLE 191 India PGD/PGS embryo testing market, by type, 2019 - 2024 (USD Million)
  • TABLE 192 India PGT (PGD/PGS) market estimates, by application, 2014 - 2018 (USD Million)
  • TABLE 193 India PGT (PGD/PGS) market forecasts, by application, 2019 - 2024 (USD Million)
  • TABLE 194 Preimplantation genetic testing costs in Singapore
  • TABLE 195 Singapore PGT (PGD/PGS) market estimates, by types, 2014 - 2018 (USD Million)
  • TABLE 196 Singapore PGT (PGD/PGS) market forecasts, by types, 2019 - 2024 (USD Million)
  • TABLE 197 Singapore PGD/PGS embryo testing market, by type, 2014 - 2018 (USD Million)
  • TABLE 198 Singapore PGD/PGS embryo testing market, by type, 2019 - 2024 (USD Million)
  • TABLE 199 Singapore PGT (PGD/PGS) market estimates, by application, 2014 - 2018 (USD Million)
  • TABLE 200 Singapore PGT (PGD/PGS) market forecasts, by application, 2019 - 2024 (USD Million)
  • TABLE 201 Average preimplantation genetic testing costs in Malaysia
  • TABLE 202 Malaysia PGT (PGD/PGS) market estimates, by types, 2014 - 2018 (USD Million)
  • TABLE 203 Malaysia PGT (PGD/PGS) market forecasts, by types, 2019 - 2024 (USD Million)
  • TABLE 204 Malaysia PGD/PGS embryo testing market, by type, 2014 - 2018 (USD Million)
  • TABLE 205 Malaysia PGD/PGS embryo testing market, by type, 2019 - 2024 (USD Million)
  • TABLE 206 Malaysia PGT (PGD/PGS) market estimates, by application, 2014 - 2018 (USD Million)
  • TABLE 207 Malaysia PGT (PGD/PGS) market forecasts, by application, 2019 - 2024 (USD Million)
  • TABLE 208 Preimplantation genetic testing costs in Brazil
  • TABLE 209 Preimplantation genetic testing costs in Argentina
  • TABLE 210 Argentina PGT (PGD/PGS) market estimates, by types, 2014 - 2018 (USD Million)
  • TABLE 211 Argentina PGT (PGD/PGS) market forecasts, by types, 2019 - 2024 (USD Million)
  • TABLE 212 Argentina PGD/PGS embryo testing market, by type, 2014 - 2018 (USD Million)
  • TABLE 213 Argentina PGD/PGS embryo testing market, by type, 2019 - 2024 (USD Million)
  • TABLE 214 Argentina PGT (PGD/PGS) market estimates, by application, 2014 - 2018 (USD Million)
  • TABLE 215 Argentina PGT (PGD/PGS) market forecasts, by application, 2019 - 2024 (USD Million)
  • TABLE 216 Chile PGT (PGD/PGS) market estimates, by types, 2014 - 2018 (USD Million)
  • TABLE 217 Chile PGT (PGD/PGS) market forecasts, by types, 2019 - 2024 (USD Million)
  • TABLE 218 Chile PGD/PGS embryo testing market, by type, 2014 - 2018 (USD Million)
  • TABLE 219 Chile PGD/PGS embryo testing market, by type, 2019 - 2024 (USD Million)
  • TABLE 220 Chile PGT (PGD/PGS) market estimates, by application, 2014 - 2018 (USD Million)
  • TABLE 221 Chile PGT (PGD/PGS) market forecasts, by application, 2019 - 2024 (USD Million)
  • TABLE 222 Preimplantation genetic testing costs in South Africa

List of Figures

  • FIG. 1 Market research process
  • FIG. 2 Information procurement
  • FIG. 3 Primary research pattern
  • FIG. 4 Market research approaches
  • FIG. 5 Value chain based sizing & forecasting
  • FIG. 6 QFD modelling for market share assessment
  • FIG. 7 Services available in different PGT (PGD/PGS) centres
  • FIG. 8 Distribution of provided services
  • FIG. 9 Percentage of IVF-PGT (PGD/PGS) clinics that perform in-house testing
  • FIG. 10 IVF treatment cycles started by type of eggs
  • FIG. 11 Market summary
  • FIG. 12 Market trends & outlook
  • FIG. 13 Market segmentation & scope
  • FIG. 14 Penetration & growth prospect mapping for product types, 2018
  • FIG. 15 Market driver relevance analysis (Current & future impact)
  • FIG. 16 Abnormality in oocytes with increasing maternal age
  • FIG. 17 Market restraint relevance analysis (Current & future impact)
  • FIG. 18 Porter's Five Forces Analysis
  • FIG. 19 Preimplantation Genetic Testing (Screening/Diagnosis) PESTEL Analysis
  • FIG. 20 Global preimplantation genetic diagnosis company market share, 2018
  • FIG. 21 U.S. preimplantation genetic diagnosis company market share, 2018
  • FIG. 22 Illumina Veriseq PGS platform vs. Thermo Fisher Ion Torrent Reproseq PGS platform
  • FIG. 23 PGT Commercial testing kits: Share break-up analysis
  • FIG. 24 PGD/PGS market types outlook key takeaways
  • FIG. 25 PGD/PGS market: types movement analysis
  • FIG. 26 Global PGD market, 2014 - 2024 (USD Million)
  • FIG. 27 Global PGS market, 2014 - 2024 (USD Million)
  • FIG. 28 Price break-up of PGS tests
  • FIG. 29 PGT (PGD/PGS) market types outlook key takeaways
  • FIG. 30 PGT (PGD/PGS) market: types movement analysis
  • FIG. 31 Global chromosomal abnormalities market, 2014 - 2024 (USD Million)
  • FIG. 32 Global X-linked diseases market, 2014 - 2024 (USD Million)
  • FIG. 33 Global embryo testing market, 2014 - 2024 (USD Million)
  • FIG. 34 Success Rate: Fresh embryos from non-donor eggs
  • FIG. 35 Global fresh embryo (own eggs) market, 2014 - 2024 (USD Million)
  • FIG. 36 Success Rate: Frozen embryos from non-donor eggs
  • FIG. 37 Global frozen embryo (own eggs) market, 2014 - 2024 (USD Million)
  • FIG. 38 Success rate: Fresh or Frozen embryos from donor eggs
  • FIG. 39 Global fresh embryo (donor eggs) market, 2014 - 2024 (USD Million)
  • FIG. 40 Global frozen embryo (donor eggs) market, 2014 - 2024 (USD Million)
  • FIG. 41 Global aneuploidy screening market, 2014 - 2024 (USD Million)
  • FIG. 42 Global HLA typing market, 2014 - 2024 (USD Million)
  • FIG. 43 Global other PGT (PGD/PGS) types market, 2014 - 2024 (USD Million)
  • FIG. 44 PGT (PGD/PGS) market: Application outlook key takeaways
  • FIG. 45 Global PGT (PGD/PGS) market: Application movement analysis
  • FIG. 46 Global identifying embryo for stem cell therapy market, 2014 - 2024 (USD Million)
  • FIG. 47 Global IVF prognosis market, 2014 - 2024 (USD Million)
  • FIG. 48 Global late onset genetic disorders market, 2014 - 2024 (USD Million)
  • FIG. 49 Global inherited genetic disease market, 2014 - 2024 (USD Million)
  • FIG. 50 Global other application market, 2014 - 2024 (USD Million)
  • FIG. 51 Regional market place: Key takeaway
  • FIG. 52 PGT (PGD/PGS) regional outlook, 2018 & 2024
  • FIG. 53 North America PGT (PGD/PGS) market, 2014 - 2024 (USD Million)
  • FIG. 54 U.S. PGT (PGD/PGS) market, 2014 - 2024 (USD Million)
  • FIG. 55 Canada PGT (PGD/PGS) market, 2014 - 2024 (USD Million)
  • FIG. 56 Europe PGT (PGD/PGS) market, 2014 - 2024 (USD Million)
  • FIG. 57 Germany PGT (PGD/PGS) market, 2014 - 2024 (USD Million)
  • FIG. 58 U.K. PGT (PGD/PGS) market, 2014 - 2024 (USD Million)
  • FIG. 59 Spain PGT (PGD/PGS) market, 2014 - 2024 (USD Million)
  • FIG. 60 Belgium PGT (PGD/PGS) market, 2014 - 2024 (USD Million)
  • FIG. 61 Czech Republic PGT (PGD/PGS) market, 2014 - 2024 (USD Million)
  • FIG. 62 Poland PGT (PGD/PGS) market, 2014 - 2024 (USD Million)
  • FIG. 63 Sweden PGT (PGD/PGS) market, 2014 - 2024 (USD Million)
  • FIG. 64 Finland PGT (PGD/PGS) market, 2014 - 2024 (USD Million)
  • FIG. 65 Norway PGT (PGD/PGS) market, 2014 - 2024 (USD Million)
  • FIG. 66 Netherlands PGT (PGD/PGS) market, 2014 - 2024 (USD Million)
  • FIG. 67 Italy PGT (PGD/PGS) market, 2014 - 2024 (USD Million)
  • FIG. 68 Asia Pacific PGT (PGD/PGS) market, 2014 - 2024 (USD Million)
  • FIG. 69 Japan PGT (PGD/PGS) market, 2014 - 2024 (USD Million)
  • FIG. 70 China PGT (PGD/PGS) market, 2014 - 2024 (USD Million)
  • FIG. 71 India PGT (PGD/PGS) market, 2014 - 2024 (USD Million)
  • FIG. 72 Singapore PGT (PGD/PGS) market, 2014 - 2024 (USD Million)
  • FIG. 73 Malaysia PGT (PGD/PGS) market, 2014 - 2024 (USD Million)
  • FIG. 74 Latin America PGT (PGD/PGS) market, 2014 - 2024 (USD Million)
  • FIG. 75 Brazil PGT (PGD/PGS) market, 2014 - 2024 (USD Million)
  • FIG. 76 Mexico PGT (PGD/PGS) market, 2014 - 2024 (USD Million)
  • FIG. 77 Argentina PGT (PGD/PGS) market, 2014 - 2024 (USD Million)
  • FIG. 78 Chile PGT (PGD/PGS) market, 2014 - 2024 (USD Million)
  • FIG. 79 Middle East & Africa PGT (PGD/PGS) market, 2014 - 2024 (USD Million)
  • FIG. 80 South Africa PGT (PGD/PGS) market, 2014 - 2024 (USD Million)
  • FIG. 81 Strategy framework
  • FIG. 82 Participant categorization
  • FIG. 83 List of companies
Back to Top